Caxton Corp

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 12Value: $5.1MLatest: 2025Q1

CAXTON CORP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 12 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "BCAX",
  "ACET",
  "MNMD",
  "KYTX",
  "LXEO",
  "IKT",
  "RZLT",
  "GLD",
  "CNTX",
  "BRK-B",
  "CRDF",
  "CMPX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 12
Total Value: 5080779
Accession Number: 0000919574-25-003127
Form Type: 13F-HR
CIK: caxton
Manager Name: Caxton

Data Enrichment

100% identified

12 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

12 positions • $5.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Rezolute, Inc.

RZLT|76200L309

Shares:1.3M

Value:$3.8M

% of Portfolio:75.3% ($3.8M/$5.1M)

SPDR GOLD TRUST

GLD|78463V107

Shares:1.3K

Value:$374.1K

% of Portfolio:7.4% ($374.1K/$5.1M)

BERKSHIRE HATHAWAY INC

BRK-B|084670702

Shares:467

Value:$248.8K

% of Portfolio:4.9% ($248.8K/$5.1M)

Mind Medicine (MindMed) Inc.

MNMD|60255C885

Shares:34.1K

Value:$199.3K

% of Portfolio:3.9% ($199.3K/$5.1M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:10.9K

Value:$142.6K

% of Portfolio:2.8% ($142.6K/$5.1M)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:43.5K

Value:$82.6K

% of Portfolio:1.6% ($82.6K/$5.1M)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:17.9K

Value:$61.9K

% of Portfolio:1.2% ($61.9K/$5.1M)

Kyverna Therapeutics, Inc.

KYTX|501976104

Shares:23.0K

Value:$44.4K

% of Portfolio:0.9% ($44.4K/$5.1M)

Cardiff Oncology, Inc.

CRDF|14147L108

Shares:13.3K

Value:$41.7K

% of Portfolio:0.8% ($41.7K/$5.1M)

Inhibikase Therapeutics, Inc.

IKT|45719W205

Shares:16.4K

Value:$35.9K

% of Portfolio:0.7% ($35.9K/$5.1M)

Adicet Bio, Inc.

ACET|007002108

Shares:17.5K

Value:$13.2K

% of Portfolio:0.3% ($13.2K/$5.1M)

Context Therapeutics Inc.

CNTX|21077P108

Shares:18.4K

Value:$11.3K

% of Portfolio:0.2% ($11.3K/$5.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Rezolute, Inc.(RZLTcusip76200L309)	1.3M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$3.8M	75.3% ($3.8M/$5.1M)	QoQ -40.81% (-$2.6M) YoY +13.72% (+$461.6K)
SPDR GOLD TRUST(GLDcusip78463V107)	1.3K	QoQ +11.03% (+129) YoY NEW(+1.3K)	All Managers (Combined)	$374.1K	7.4% ($374.1K/$5.1M)	QoQ +32.15% (+$91.0K) YoY NEW(+$374.1K)
BERKSHIRE HATHAWAY INC(BRK-Bcusip084670702)	467	QoQ -58.78% (-666) YoY -54.17% (-552)	All Managers (Combined)	$248.8K	4.9% ($248.8K/$5.1M)	QoQ -51.55% (-$264.7K) YoY -41.90% (-$179.5K)
Mind Medicine (MindMed) Inc.(MNMDcusip60255C885)	34.1K	QoQ 0.00% (-0) YoY +17.23% (-5.0K)	All Managers (Combined)	$199.3K	3.9% ($199.3K/$5.1M)	QoQ -15.94% (-$37.8K) YoY -27.04% (-$73.9K)
Bicara Therapeutics Inc.(BCAXcusip055477103)	10.9K	QoQ 0.00% (-0) YoY NEW(+10.9K)	All Managers (Combined)	$142.6K	2.8% ($142.6K/$5.1M)	QoQ -25.20% (-$48.0K) YoY NEW(+$142.6K)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	43.5K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$82.6K	1.6% ($82.6K/$5.1M)	QoQ +31.03% (+$19.6K) YoY -4.04% (-$3.5K)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	17.9K	QoQ 0.00% (-0) YoY +72.99% (-7.5K)	All Managers (Combined)	$61.9K	1.2% ($61.9K/$5.1M)	QoQ -47.26% (-$55.5K) YoY -61.71% (-$99.9K)
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	23.0K	QoQ 0.00% (-0) YoY +45.02% (-7.1K)	All Managers (Combined)	$44.4K	0.9% ($44.4K/$5.1M)	QoQ -48.39% (-$41.6K) YoY -88.73% (-$349.3K)
Cardiff Oncology, Inc.(CRDFcusip14147L108)	13.3K	QoQ 0.00% (-0) YoY NEW(+13.3K)	All Managers (Combined)	$41.7K	0.8% ($41.7K/$5.1M)	QoQ -27.64% (-$15.9K) YoY NEW(+$41.7K)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	16.4K	QoQ 0.00% (-0) YoY NEW(+16.4K)	All Managers (Combined)	$35.9K	0.7% ($35.9K/$5.1M)	QoQ -32.61% (-$17.4K) YoY NEW(+$35.9K)
Adicet Bio, Inc.(ACETcusip007002108)	17.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.2K	0.3% ($13.2K/$5.1M)	QoQ -21.51% (-$3.6K) YoY -67.87% (-$27.9K)
Context Therapeutics Inc.(CNTXcusip21077P108)	18.4K	QoQ 0.00% (-0) YoY NEW(+18.4K)	All Managers (Combined)	$11.3K	0.2% ($11.3K/$5.1M)	QoQ -41.71% (-$8.1K) YoY NEW(+$11.3K)